Point72 Hong Kong LTD Rhythm Pharmaceuticals, Inc. Transaction History

Point72 Hong Kong LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$13.16 - $22.9 $1,210 - $2,106	-92 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$19.53 - $25.5 $5,194 - $6,783	-266 Reduced 74.3%	92 $2,000
Q3 2019 Nov 14, 2019	SELL	$18.62 - $24.51 $19,551 - $25,735	-1,050 Reduced 74.57%	358 $8,000
Q2 2019 Aug 14, 2019	BUY	$21.11 - $28.48 $29,722 - $40,099	1,408 New	1,408 $31,000
Q3 2018 Nov 14, 2018	SELL	$26.99 - $35.85 $23,535 - $31,261	-872 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$17.02 - $35.2 $14,841 - $30,694	872 New	872 $27,000

192

67.3M

834K

78.6K

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.13B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.